Baby Brent’s Bill
To direct the Federal Trade Commission to conduct an investigation and submit to Congress a report on unfair or deceptive acts or practices that may be prevalent in the advertising or marketing of preterm infant formula and to issue regulations to prohibit unfair or deceptive acts or practices related to the advertising or marketing of preterm infant formula, and for other purposes.
This bill, known as "Baby Brent’s Bill," aims to address concerns about the advertising and marketing of preterm infant formula. It proposes that the Federal Trade Commission (FTC) investigate and report to Congress on any unfair or deceptive practices in this area. Based on the investigation, the FTC would then issue regulations to prevent such practices.
The bill would primarily affect manufacturers and marketers of preterm infant formula. If passed, it could lead to stricter regulations and oversight in how these products are advertised and marketed, potentially protecting consumers from misleading information.
As of July 27, 2026, the bill has just been introduced in the House and referred to the House Committee on Energy and Commerce. No further action has been taken yet. The bill is currently in its initial stages of the legislative process.
